Fox Foundation for Parkinson's Research - pre-proposals

* Target Validation: Supports work demonstrating whether modulation of a novel biological target has impact in a PD-relevant animal model, an essential early step to the development of potential targeted therapies. Funding: $250K for 2 years.
* Therapeutics Development Initiative: Supports preclinical PD research at for-profit institutions, this funding program seeks to support preclinical development of Parkinson’s disease therapies which have the potential for fundamentally altering disease course and/or improving treatment of symptoms above and beyond current standards of care. Proposals must focus on key and critical preclinical studies necessary for developing, optimizing and evaluating therapeutic strategies that, if successful, can move into human testing. No budget limit, 2 years projects.
http://www.michaeljfox.org/research_fundingOpportunities_program.cfm?SegmentID=1

.